Thomson Medical Group Limited (SGX:A50)
Singapore · Delayed Price · Currency is SGD 0.0530
-0.0010 (-1.85%)
Sep 3, 2026, 1:37 PM SGT
Thomson Medical Group Income Statement
Financials in millions SGD. Fiscal year is July - June.
Millions SGD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 420.08 | 394.66 | 351.15 | 355.77 | 333.71 |
Other Revenue | 6.51 | 60.87 | 31.5 | 4.79 | 4.79 |
| 426.59 | 455.53 | 382.65 | 360.56 | 338.5 | |
Revenue Growth | -6.35% | 19.04% | 6.13% | 6.52% | 40.81% |
Cost of Revenue | 251.08 | 234.82 | 197.52 | 177.35 | 163.24 |
Gross Profit | 175.5 | 220.71 | 185.14 | 183.21 | 175.26 |
Other Operating Expenses | 92.98 | 90.98 | 83.24 | 79.88 | 65.52 |
Operating Expenses | 133.96 | 129.67 | 111.61 | 100.95 | 83.45 |
Operating Income | 41.54 | 91.04 | 73.52 | 82.26 | 91.81 |
Interest Expense | -49.2 | -59.66 | -51.55 | -30.51 | -23.5 |
Interest & Investment Income | 1.8 | 3.62 | 7.38 | 3.95 | 0.99 |
Earnings From Equity Investments | -0.02 | -0.48 | -0.19 | -0.49 | - |
EBT Excluding Unusual Items | -5.88 | 34.52 | 29.16 | 55.2 | 69.3 |
Impairment of Goodwill | -15.25 | -75.13 | - | - | - |
Pretax Income | -21.13 | -40.62 | 29.16 | 55.2 | 69.3 |
Income Tax Expense | 6.67 | 6.36 | 10.94 | 14.15 | 10.71 |
Earnings From Continuing Operations | -27.79 | -46.98 | 18.21 | 41.06 | 58.59 |
Net Income to Company | -27.79 | -46.98 | 18.21 | 41.06 | 58.59 |
Minority Interest in Earnings | -1.91 | -0.6 | -4.06 | -4.5 | -4.82 |
Net Income | -29.7 | -47.58 | 14.16 | 36.56 | 53.76 |
Net Income to Common | -29.7 | -47.58 | 14.16 | 36.56 | 53.76 |
Net Income Growth | - | - | -61.27% | -32.01% | 277.62% |
Shares Outstanding (Basic) | 26,442 | 26,441 | 26,441 | 26,441 | 26,441 |
Shares Outstanding (Diluted) | 26,442 | 26,441 | 26,459 | 26,447 | 26,441 |
Shares Change | 0.00% | -0.07% | 0.05% | 0.02% | - |
EPS (Basic) | -0.00 | -0.00 | 0.00 | 0.00 | 0.00 |
EPS (Diluted) | -0.00 | -0.00 | 0.00 | 0.00 | 0.00 |
EPS Growth | - | - | -61.20% | -32.04% | 277.14% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | 55.64 | 37.87 | 56.49 | 77.39 | 65.05 |
Free Cash Flow Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend Per Share | - | - | - | 0.000 | - |
Dividend Growth | - | - | - | - | - |
Gross Margin | 41.14% | 48.45% | 48.38% | 50.81% | 51.78% |
Operating Margin | 9.74% | 19.99% | 19.21% | 22.81% | 27.12% |
Profit Margin | -6.96% | -10.44% | 3.70% | 10.14% | 15.88% |
Free Cash Flow Margin | 13.04% | 8.31% | 14.76% | 21.46% | 19.22% |
EBITDA | 68.59 | 120.71 | 94.14 | 95.42 | 102.95 |
EBITDA Margin | 16.08% | 26.50% | 24.60% | 26.46% | 30.41% |
D&A For EBITDA | 27.04 | 29.67 | 20.61 | 13.16 | 11.14 |
EBIT | 41.54 | 91.04 | 73.52 | 82.26 | 91.81 |
EBIT Margin | 9.74% | 19.99% | 19.21% | 22.81% | 27.12% |
Effective Tax Rate | - | - | 37.53% | 25.63% | 15.46% |